Expo Hub
ISTH 2025
June 21-25, Washington D.C., USA
Specialty testing, special needs.
Accelerate testing. Boost performance.
Hemostasis and hematology testing often require significant hands-on time due to factors like sample preparation, interpretation, troubleshooting, and manual review, especially for complex procedures. Labs need solutions that reduce manual touchpoints, particularly when specialized skills are required. Siemens Healthineers provides specialty solutions that help labs cut manual tasks, reduce footprint, and simplify sample management.
Testing solutions
Rely on a variety of state-of-the-art lab equipment
Unlock the power of a comprehensive suite of integrated blood testing solutions, featuring advanced optical methods, routine platelet aggregation testing, and AI-driven full-field imaging. See how our portfolio helps you tackle staffing challenges and enhance efficiency across your entire testing workflow.
At the booth
CN-3000 and CN-6000 Systems1
See how the CN-3000 and CN-6000 Hemostasis Systems1 are designed to transform coagulation testing with fast, smart, and flexible solutions—all in a compact design. Learn how features like automated barcode scanning and cap piercing can help your lab reduce manual steps and improve efficiency.
Download brochure
Edoxaban testing now available!2
INNOVANCE Anti-Xa assay
Discover how the INNOVANCE Anti-Xa assay brings advanced, automated testing to your lab. The assay is designed for fast, reliable measurement of UFH, LMWH, and direct oral anticoagulants like rivaroxaban, apixaban, and edoxaban.2 With zero hands-on time, this chromogenic assay helps reduce human error and streamline your workflow.
New! Companion diagnostic for QFITLIA (fitusiran)
INNOVANCE Antithrombin assay
INNOVANCE Antithrombin assay is the first and only FDA-cleared companion diagnostic for QFITLIA (fitusiran) in the U.S.3 The liquid assay delivers consistent results across systems, supporting harmonized interpretation and reducing repeat testing—saving both time and reagents.
At the booth
Atellica HEMA 580 Analyzer4
Atellica HEMA 570 and 580 Analyzers4 are high-throughput hematology systems designed to meet the demands of modern, high-volume laboratories. Both analyzers share a compact footprint and are engineered for seamless integration with advanced informatics and automation solutions, enhancing workflow efficiency across diverse laboratory settings.
At the booth
Scopio Digital Cell Morphology
Experience the power of Scopio X100 and X100HT—the first full-field digital cell morphology platforms with AI-driven decision support to enhance accuracy and efficiency. These cutting-edge systems automate slide scanning, helping eliminate manual reviews and saving valuable time in your lab.
Lab automation and IT
Connect the dots and streamline workflows across disciplines
Explore our scalable and customizable portfolio of automated lab and IT solutions designed to streamline workflows in labs of all sizes. See how our technologies help improve diagnostic accuracy while freeing up time from routine tasks.
Less handling, more insight
Many conditions involve both hematological and hemostatic factors, making integrated testing key to faster, more efficient diagnoses. Collaboration across disciplines helps uncover clearer insights—especially in complex cases like coagulopathies or thrombocytopenia. See how Atellica Diagnostics IT brings it all together by consolidating data from multiple sources, reducing manual entry, and delivering a complete clinical picture.
Flexible solutions, standardized results
Our adaptable portfolio of automated lab solutions is designed to meet diverse needs, spaces, and specialized requirements, improving workflows in labs of any size. Discover flexible, innovative options to boost standardization and enhance workflow efficiency through lab automation.
New! Connect Atellica HEMA 570 and 580 Analyzers4
Reduce time and effort spent on low-value tasks and complex workstreams by connecting Atellica HEMA 570 and 580 Analyzers.4 Automation connectivty helps improve resource utilization, increase efficiency, and achieve consistent turnaround times.
Automation in just 8m2
Could lab automation from Siemens Healthineers be the solution for your lab? Automate hemostasis and hematology in a compact workcell, with single-tube transport, centrifugation, and automatic aliquoting to reduce manual steps, expand your test menu, and free up time—all in a small footprint. Learn about the wins.
Flexible layout
Our lab automation solutions let you flexibly add analyzers and workflow modules, like pre- and post-analytics, to fit your space and needs. Together with our healthcare consulting specialists, tailor a configuration that meets your clinical and operational needs and helps you achieve more with less.
Automation for every lab
Unlock holistic insights into blood science with versatile automation—whether for single- or multidisciplinary testing. From clinical chemistry and immunoassay to hemostasis, hematology, plasma proteins, and allergy testing, streamline it all with one trusted partner and simplify your lab’s vendor management.
Bleeding management
Accelerate clinical insights. Boost patient outcomes.
Our extensive range of routine and specialty hemostasis assays supports informed diagnostic and treatment decisions. We’re continually expanding with new technologies and ready-to-use solutions to simplify tasks and improve workflows. Discover how to gain deeper clinical insights in bleeding management.
Improve bleeding risk assessment
Most VWD cases are congenital, but certain chronic diseases and therapies can trigger an acquired form of the disorder. Explore our resources for the latest testing guidelines and diagnostic advancements, and save time investigating best practices and current standards.
Explore our unparalleled bleeding portfolio
Streamline diagnostic testing around primary and secondary hemostasis with tests for acquired and congenital bleeding risk assessment and therapy , from one provider.
Now available in the U.S. INNOVANCE VWF Ac and vWF Ag assays
Elevate VWF diagnostics with a highly sensitive, precise, and innovative initial testing panel for von Willebrand disease. Strong precision at key decision points helps reduce repeat tests and unnecessary blood draws.
INNOVANCE PFA-200 System4
An automated platelet function analyzer designed for assessing inherited, acquired, or drug-induced platelet dysfunction—all from a single sample tube, reducing handling and simplifying the process.
Integrated platelet aggregation testing4
Designed for making aggregation testing easier, more reliable, and standardized: automating platelet aggregation for five agonists with no extra pipetting or hands-on steps required.
Bleeding portfolio overview
A comprehensive bleeding risk assessment portfolio of systems and assays.
Scientific posters
Get insights on apixaban and QFITLIA (fitusiran) testing
Poster PB0784: Antithrombin activity measurement via the INNOVANCE Antithrombin assay to manage fitusiran dosing
Abstract: Fitusiran is an investigational subcutaneous prophylactic small interfering RNA (siRNA) therapeutic that lowers antithrombin (AT) to rebalance hemostasis by increasing thrombin generation in patients with Hemophilia A/B. To optimize the benefit-risk of fitusiran, an antithrombin-based dosing regimen (AT-DR) targeting AT activity between 15-35% of norm was implemented in clinical studies. Fitusiran dosing is individually adjusted based on AT measurement and thus requires an AT activity assay with high analytical sensitivity and high precision especially at the low end of the measuring range (≤ 20% of norm). The objective of this study was to evaluate the analytical performance requirements of the INNOVANCE Antithrombin assay for fitusiran monitoring.
Poster PB0189: Quantitative determination of apixaban: method comparison studies between different assays and platforms
Abstract: Apixaban is a direct oral anticoagulant (DOAC) inhibiting highly selective FXa. Although laboratory monitoring of DOACs is not per se required, there is a growing recognition of the need to test in specific clinical situations and patient populations. The quantitative determination of DOACs is possible with chromogenic anti-Xa assays originally developed for determination of heparin using drug-specific calibrators. The study evaluates the comparability of the INNOVANCE Anti-Xa assay calibrated with apixaban-specific standards (Siemens Healthineers) to other commercial methods and liquid chromatography tandem mass spectrometry (LC-MS/MS). We also investigated the INNOVANCE Anti-Xa assay comparability on different systems.
The trusted hemostasis partner you can count on
Let’s go beyond hemostasis testing—today, tomorrow, and in the future
Siemens Healthineers provides flexible, expansive portfolio solutions across the core lab, including hemostasis, clinical chemistry, immunoassay, hematology, urinalysis, automation, and IT solutions, combined with vast experience and service excellence, to meet the needs of labs in all segments.
Our 60+ years of leadership in hemostasis testing is built on a strong scientific legacy of innovation in reagent development. Our hemostasis testing portfolio comprises >60 assays, including trusted, ready-to-use, highly precise INNOVANCE assays, as well as a scalable selection of coagulation analyzers from Siemens Healthineers. Whether you require a stand-alone hemostasis solution, automated hemostasis testing, or hemostasis testing combined with specific or multidisciplinary testing enhanced by digitalization, we can provide it all.
We look forward to meeting you in Washington at ISTH 2025!
Pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
We look forward to seeing you at ISTH 2025 in Wahington D.C.!
Meet us at booth #421
Date: June 21 – 25, 2025
Exhibition dates and hours:
June 21: 6:30–7:30 pm (Opening Reception/Exhibition Hall Open)
June 22-24: 10:00 am–5:00 pm
Location: Washington D.C., USA
Venue: Walter E. Washington Convention Center
(maps)
Are you interested?
Share
Do you find this page interesting? Share it with your peers.
1Investigational device - pending 510(k) clearance: under FDA review. Not available for sale in the U.S.
2Rivaroxaban and edoxaban testing are not available for sale in the U.S.
3As of May 2025.
4Not available for sale in the U.S.
All trademarks and brands are the property of their respective owners.CN-3000 and CN-6000 Systems refer to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000 respectively.
Product availability may vary from country to country and is subject to varying regulatory requirements. The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed. Please contact your local representative for availability.